The increasing demand for specific immunological investigation and therapeutic design has spurred significant improvements in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently generated using diverse expression methods, including bacterial hosts, mammalian cell lines, and